Latest News and Press Releases

NEW YORK, March 22, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of FAT Brands Inc. (“FAT” or the “Company”) (NASDAQ: FAT).   Such investors are advised to...

NEW YORK, March 22, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Graphite Bio, Inc. (“Graphite” or the “Company”) (NASDAQ: GRPH). Such investors are...

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma, Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP).   Such investors are...

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Quest Diagnostics Incorporated (“Quest” or the “Company”) (NYSE: DGX). Such investors are...

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MoneyLion Inc. (“MoneyLion” or the “Company”) (NYSE: ML).   Such investors are advised to...

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Natera, Inc. (“Natera” or the “Company”) (NASDAQ: NTRA).   Such investors are advised to...

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Yext, Inc. (“Yext” or the “Company”) (NYSE: YEXT).   Such investors are advised to...

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DiDi Global Inc. (“DiDi” or the “Company”) (NYSE: DIDI).   Such investors are advised to...

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NextEra Energy, Inc. (“NextEra” or the “Company”) (NYSE: NEE). Such investors are advised...

NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Finch Therapeutics Group, Inc. (“Finch” or the “Company”) (NASDAQ: FNCH).   Such...